This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2001 Sep 22;358(9286):948-9.

doi: 10.1016/S0140-6736(01)06113-X.

Back to nephrectomy for patients with metastatic renal cancer

L Klotz¹

Affiliations

PMID: 11583744
DOI: 10.1016/S0140-6736(01)06113-X

Comment

Back to nephrectomy for patients with metastatic renal cancer

L Klotz. Lancet. 2001.

. 2001 Sep 22;358(9286):948-9.

doi: 10.1016/S0140-6736(01)06113-X.

Author

L Klotz¹

Affiliation

¹ Department of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Ontario M4N 3M5, Toronto, Canada. Laurence.Klotz@swchsc.on.ca

PMID: 11583744
DOI: 10.1016/S0140-6736(01)06113-X

No abstract available

PubMed Disclaimer

Comment on

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.
Mickisch GH, Garin A, van Poppel H, de Prijck L, Sylvester R; European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary Group. Mickisch GH, et al. Lancet. 2001 Sep 22;358(9286):966-70. doi: 10.1016/s0140-6736(01)06103-7. Lancet. 2001. PMID: 11583750 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information